Cargando…

Investigation on Patient/Compensator Scatter Factor for Monitor Unit Calculation in Proton Therapy

PURPOSE: It is the goal of this study to use both Monte Carlo (MC) simulation and the pencil beam dose algorithm (PBA) in the treatment planning system to investigate Patient scatter factor (PSF) and Compensator scatter factor (CSF) for calibrating the dose per monitor unit (DMU) for a passive scatt...

Descripción completa

Detalles Bibliográficos
Autores principales: Prusator, Michael T., Ahmad, Salahuddin, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874192/
https://www.ncbi.nlm.nih.gov/pubmed/31773033
http://dx.doi.org/10.14338/IJPT-18-00021.1
_version_ 1783472795096711168
author Prusator, Michael T.
Ahmad, Salahuddin
Chen, Yong
author_facet Prusator, Michael T.
Ahmad, Salahuddin
Chen, Yong
author_sort Prusator, Michael T.
collection PubMed
description PURPOSE: It is the goal of this study to use both Monte Carlo (MC) simulation and the pencil beam dose algorithm (PBA) in the treatment planning system to investigate Patient scatter factor (PSF) and Compensator scatter factor (CSF) for calibrating the dose per monitor unit (DMU) for a passive scattering proton therapy system. MATERIALS AND METHODS: PSFs and CSFs for brain, lung, pancreas, and prostate treatment sites were calculated by using MC simulation and PBA from the treatment planning software to evaluate the agreement between the two. RESULTS: This study shows that the CSF values are always greater than 1, with some reaching nearly 4% above unity, and depending strongly on the shape of the compensator. Monte Carlo and PBA-calculated CSF factors agree very well, with average differences below 1%. PSF values calculated in this study ranged from 0.919 to 1.023 and are largely dependent on the type of tissue heterogeneities in the treatment field. Monte Carlo and PBA-calculated PSF factors show differences, with the largest discrepancies seen in lung cases, with an average difference of 1.9%. It is also shown that dense bone will drive a PSF to values greater than unity, while large quantities of air decrease the PSF to below unity. CONCLUSION: We have showed that the compensator and patient anatomy can have a significant impact on clinical proton dose distribution. It is recommended that both Monte Carlo and treatment planning system should be used to take these factors into account in the final DMU calculation.
format Online
Article
Text
id pubmed-6874192
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Particle Therapy Co-operative Group
record_format MEDLINE/PubMed
spelling pubmed-68741922019-11-26 Investigation on Patient/Compensator Scatter Factor for Monitor Unit Calculation in Proton Therapy Prusator, Michael T. Ahmad, Salahuddin Chen, Yong Int J Part Ther Original Articles PURPOSE: It is the goal of this study to use both Monte Carlo (MC) simulation and the pencil beam dose algorithm (PBA) in the treatment planning system to investigate Patient scatter factor (PSF) and Compensator scatter factor (CSF) for calibrating the dose per monitor unit (DMU) for a passive scattering proton therapy system. MATERIALS AND METHODS: PSFs and CSFs for brain, lung, pancreas, and prostate treatment sites were calculated by using MC simulation and PBA from the treatment planning software to evaluate the agreement between the two. RESULTS: This study shows that the CSF values are always greater than 1, with some reaching nearly 4% above unity, and depending strongly on the shape of the compensator. Monte Carlo and PBA-calculated CSF factors agree very well, with average differences below 1%. PSF values calculated in this study ranged from 0.919 to 1.023 and are largely dependent on the type of tissue heterogeneities in the treatment field. Monte Carlo and PBA-calculated PSF factors show differences, with the largest discrepancies seen in lung cases, with an average difference of 1.9%. It is also shown that dense bone will drive a PSF to values greater than unity, while large quantities of air decrease the PSF to below unity. CONCLUSION: We have showed that the compensator and patient anatomy can have a significant impact on clinical proton dose distribution. It is recommended that both Monte Carlo and treatment planning system should be used to take these factors into account in the final DMU calculation. The Particle Therapy Co-operative Group 2018-11-30 2018 /pmc/articles/PMC6874192/ /pubmed/31773033 http://dx.doi.org/10.14338/IJPT-18-00021.1 Text en © Copyright 2018 International Journal of Particle Therapy http://creativecommons.org/licenses/by/3.0/ Distributed under Creative Commons CC-BY
spellingShingle Original Articles
Prusator, Michael T.
Ahmad, Salahuddin
Chen, Yong
Investigation on Patient/Compensator Scatter Factor for Monitor Unit Calculation in Proton Therapy
title Investigation on Patient/Compensator Scatter Factor for Monitor Unit Calculation in Proton Therapy
title_full Investigation on Patient/Compensator Scatter Factor for Monitor Unit Calculation in Proton Therapy
title_fullStr Investigation on Patient/Compensator Scatter Factor for Monitor Unit Calculation in Proton Therapy
title_full_unstemmed Investigation on Patient/Compensator Scatter Factor for Monitor Unit Calculation in Proton Therapy
title_short Investigation on Patient/Compensator Scatter Factor for Monitor Unit Calculation in Proton Therapy
title_sort investigation on patient/compensator scatter factor for monitor unit calculation in proton therapy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874192/
https://www.ncbi.nlm.nih.gov/pubmed/31773033
http://dx.doi.org/10.14338/IJPT-18-00021.1
work_keys_str_mv AT prusatormichaelt investigationonpatientcompensatorscatterfactorformonitorunitcalculationinprotontherapy
AT ahmadsalahuddin investigationonpatientcompensatorscatterfactorformonitorunitcalculationinprotontherapy
AT chenyong investigationonpatientcompensatorscatterfactorformonitorunitcalculationinprotontherapy